ALLK Insider Trading
Insider Ownership Percentage: 16.12%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $87,934.64
Allakos Share Price & Price History
Current Price: $1.12
Price Change: ▲ Price Increase of +0.01 (0.90%)
As of 01/22/2025 05:00 PM ET
Allakos Insider Trading History
Allakos Institutional Trading History
Data available starting January 2016
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Read More on Allakos
Volume
540,110 shs
Average Volume
1,117,001 shs
Market Capitalization
$100.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Who are the company insiders with the largest holdings of Allakos?